BioXcel Therapeutics Inc (BTAI)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
2,313,500
EV to revenue ratio (TTM)
125.57
EV to ebitda
-0.755
Financial Performance
Revenue (TTM)
742,000
Gross profit (TTM)
394,000
EBITDA
-44,507,000
Profitability
Operating margin (TTM)
-5,601.00%
Profit margin
0.00%
Return on assets (TTM)
-102.40%
Return on equity (TTM)
-1,767.00%
Per Share Metrics
Revenue per share (TTM)
0.03
EPS
-2.58
Diluted EPS (TTM)
-2.58
Book value
-3.69
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
3.118
Price to book ratio (TTM)
27.5
Growth
Quarterly earnings growth (YoY)
51.70%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
0.188